<DOC>
	<DOC>NCT00479687</DOC>
	<brief_summary>This clinical trial is to determine the safety and effectiveness of three injections of SUPARTZ (sodium hyaluronate) compared with saline (placebo) for the treatment of glenohumeral osteoarthritis of the shoulder. The trial contains two phases. In the first phase subjects are randomized to either SUPARTZ or placebo treatment. The second phase of the trial is open-label so all subjects will receive SUPARTZ injections only.</brief_summary>
	<brief_title>SUPARTZ Versus Placebo in Osteoarthritis of the Shoulder</brief_title>
	<detailed_description>Phase III Multi-center, randomized study to determine the safety and efficacy of injections of SUPARTZ for Osteoarthritis of the Shoulder</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Hyaluronic Acid</mesh_term>
	<criteria>Glenohumeral OA confirmed by radiograph Limitation of shoulder motion in at least one direction Full thickness rotator cuff tear or rotator cuff tendonopathy Frozen shoulder Female who is pregnant or lactating</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Osteoarthritis</keyword>
	<keyword>Shoulder</keyword>
	<keyword>HA</keyword>
</DOC>